SCHEMBL6572574

SCHEMBL6572574

NC(=NNCC(O)O)NN=Cc1cccc(O)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.52
ALDH1A1 P00352 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
POLB P06746 1/20 0.44
CYP2D6 P10635 1/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
MAPT P10636 3/20 0.43
GAA P10253 2/20 0.43
STS P08842 1/20 0.42
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MAOB P27338 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6573978 0.87 POLB (0.44) GFERPOLBRAB9AMAOBMEN1
SCHEMBL6573502 0.78 GFER (0.64) GFERALDH1A1NPSR1POLBCYP2D6
Hydrochloric Acid SCHEMBL7266206 0.76 GFER (0.62) GFERALDH1A1NPSR1POLBCYP2D6
SCHEMBL6572560 0.75 GFER (0.54) GFERALDH1A1NPSR1POLBCYP2D6
SCHEMBL7743081 0.73 GFER (0.66) GFERALDH1A1NPSR1POLBCYP2D6
SCHEMBL31222602 0.73 POLB (0.81) GFERPOLBKDM4EMAOB
SCHEMBL5181515 0.73 POLB (0.81) GFERPOLBKDM4EMAOB
SCHEMBL7743084 0.73 GFER (0.66) GFERALDH1A1NPSR1POLBCYP2D6
SCHEMBL1520066 0.73 GFER (0.66) GFERALDH1A1NPSR1POLBCYP2D6
SCHEMBL942480 0.73 POLB (0.81) GFERPOLBKDM4EMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1120405-B1 Oxidation bases with a guanidine chain, process for their preparation, their use for oxidation dyeing of keratinous fibers, dyeing compositions and dyeing processes OREAL (FR) 2004-10-27 EP claimed
US-20010034913-A1 Novel oxidation bases containing a guanidine chain, process for preparing them, their use for the oxidation dyeing of keratin fibers, dye compositions and dyeing processes L'OREAL S.A. (FR) 2001-11-01 US claimed
EP-1120405-A2 Oxidation bases with a guanidine chain, process for their preparation, their use for oxidation dyeing of keratinous fibers, dyeing compositions and dyeing processes L'OREAL (FR) 2001-08-01 EP claimed
EP-1120405-B1 Oxidation bases with a guanidine chain, process for their preparation, their use for oxidation dyeing of keratinous fibers, dyeing compositions and dyeing processes OREAL (FR) 2004-10-27 EP disclosed
US-6652600-B2 Oxidation color dye L'OREAL S.A. (FR) 2003-11-25 US disclosed
US-20010034913-A1 Novel oxidation bases containing a guanidine chain, process for preparing them, their use for the oxidation dyeing of keratin fibers, dye compositions and dyeing processes L'OREAL S.A. (FR) 2001-11-01 US disclosed
EP-1120405-A2 Oxidation bases with a guanidine chain, process for their preparation, their use for oxidation dyeing of keratinous fibers, dyeing compositions and dyeing processes L'OREAL (FR) 2001-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010034913-A1 Novel oxidation bases containing a guanidine chain, process for preparing them, their use for the oxidation dyeing of keratin fibers, dye compositions and dyeing processes KRT18, OGG1, UNG GFER 978/4885ALDH1A1 785/4885NPSR1 4377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.